Segment Wealth Management LLC cut its position in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 11.6% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 13,049 shares of the company's stock after selling 1,719 shares during the period. Segment Wealth Management LLC's holdings in Procter & Gamble were worth $2,079,000 at the end of the most recent quarter.
Several other large investors also recently added to or reduced their stakes in PG. Kingstone Capital Partners Texas LLC raised its holdings in shares of Procter & Gamble by 655,209.0% in the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company's stock valued at $11,832,680,000 after purchasing an additional 76,017,350 shares in the last quarter. Northern Trust Corp increased its stake in Procter & Gamble by 0.8% during the 1st quarter. Northern Trust Corp now owns 29,644,000 shares of the company's stock valued at $5,051,930,000 after purchasing an additional 248,792 shares in the last quarter. Price T Rowe Associates Inc. MD increased its stake in shares of Procter & Gamble by 13.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock worth $3,660,737,000 after acquiring an additional 2,466,308 shares during the period. Goldman Sachs Group Inc. increased its stake in shares of Procter & Gamble by 3.5% in the first quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company's stock worth $2,966,252,000 after acquiring an additional 583,629 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in Procter & Gamble by 6.3% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 17,293,428 shares of the company's stock worth $2,947,146,000 after buying an additional 1,018,865 shares in the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
PG has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. reissued a "neutral" rating and set a $170.00 price target (down from $178.00) on shares of Procter & Gamble in a report on Friday, July 25th. Barclays decreased their price objective on shares of Procter & Gamble from $164.00 to $153.00 and set an "equal weight" rating on the stock in a report on Wednesday. Wells Fargo & Company decreased their price target on shares of Procter & Gamble from $173.00 to $170.00 and set an "overweight" rating on the stock in a research note on Thursday, September 25th. BNP Paribas Exane decreased their price target on shares of Procter & Gamble from $177.00 to $172.00 and set an "outperform" rating on the stock in a research note on Tuesday, September 23rd. Finally, Berenberg Bank lifted their target price on shares of Procter & Gamble from $152.00 to $154.00 and gave the stock a "hold" rating in a research note on Wednesday, September 17th. Eleven research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $173.11.
View Our Latest Stock Report on PG
Procter & Gamble Price Performance
Shares of PG opened at $152.19 on Friday. Procter & Gamble Company has a 1-year low of $149.91 and a 1-year high of $180.43. The stock has a market cap of $356.20 billion, a PE ratio of 23.38, a P/E/G ratio of 4.01 and a beta of 0.36. The firm has a 50-day simple moving average of $155.51 and a two-hundred day simple moving average of $160.06. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, beating analysts' consensus estimates of $1.42 by $0.06. The business had revenue of $20.89 billion during the quarter, compared to analysts' expectations of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The business's revenue for the quarter was up 1.7% on a year-over-year basis. During the same period last year, the business earned $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, analysts forecast that Procter & Gamble Company will post 6.91 EPS for the current year.
Procter & Gamble Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were issued a $1.0568 dividend. The ex-dividend date was Friday, July 18th. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.8%. Procter & Gamble's payout ratio is 64.98%.
Insider Buying and Selling
In related news, CEO Jon R. Moeller sold 40,119 shares of Procter & Gamble stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $6,309,515.13. Following the completion of the transaction, the chief executive officer owned 319,375 shares in the company, valued at $50,228,106.25. The trade was a 11.16% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Andre Schulten sold 11,638 shares of Procter & Gamble stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $1,830,308.26. Following the completion of the transaction, the chief financial officer owned 52,642 shares of the company's stock, valued at $8,279,007.34. This represents a 18.11% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 120,181 shares of company stock valued at $18,918,012 over the last ninety days. 0.20% of the stock is currently owned by corporate insiders.
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report